HAS2 and carcinoma: HAS1 mRNA were overexpressed in effusions, in contrast to primary carcinomas and solid metastases, whilst HAS2 mRNA was overexpressed in solid metastases and primary carcinomas compared to effusions and HAS3 mRNA was overexpressed in all subtypes.